Aug 6, 2026 09:15AM
Aug 6, 2026 09:15AM
Jul 1, 2026 09:01AM
Jul 1, 2026 09:00AM
Jun 22, 2026 09:15AM
Jun 22, 2026 09:15AM
Apr 28, 2026 09:02AM Creative Medical reports 93% response rate in knee osteoarthritis study
Apr 28, 2026 09:01AM
Jan 13, 2026 09:15AM
Jan 13, 2026 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 2, 2025 09:15AM Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201
Oct 27, 2025 08:15AM
Oct 27, 2025 08:15AM
Aug 13, 2025 09:01AM
Aug 13, 2025 09:01AM
Mar 20, 2025 07:50AM
Mar 20, 2025 07:50AM
Feb 20, 2025 08:00AM Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
Feb 14, 2025 07:00AM
Feb 11, 2025 09:25AM
Feb 11, 2025 09:25AM
Nov 13, 2024 09:01AM
Nov 13, 2024 09:00AM
Jul 24, 2024 09:03AM
Jul 24, 2024 09:00AM Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program
Jul 10, 2024 08:32AM
Jul 10, 2024 08:30AM
Jun 24, 2024 08:30AM
Mar 27, 2024 09:00AM
Mar 7, 2024 09:15AM
Mar 7, 2024 09:15AM
Mar 6, 2024 07:00AM Creative Medical Technology (CELZ) Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Mar 6, 2024 07:00AM
Dec 20, 2023 09:38AM
Dec 20, 2023 09:33AM
Nov 15, 2023 08:00AM
Oct 10, 2023 08:00AM
Sep 19, 2023 08:01AM
Sep 19, 2023 08:00AM Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
Aug 24, 2023 10:45AM
Jul 13, 2023 09:00AM
Jun 12, 2023 08:00AM
Jun 12, 2023 08:00AM
Apr 12, 2023 08:01AM
Apr 12, 2023 08:00AM
Apr 4, 2023 08:00AM Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update
Mar 23, 2023 08:00AM

328,460 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All